Imatinib dispensed and purchased in calendar year 2021

Thank you for your request dated 4 April 2022 under the Official Information Act 1982 (OIA) for information relating to imatinib. You requested: 

The total quantities of Imatinib Mesilate as funded by Pharmac for the most recent twelve month period. 

  1. Imatinib-Rex          Cap 100mg   2594315      per 60
  2. Imatinib-Rex          Cap 400mg   2594323      per 30
  3. Glivec (Novartis)   Tab 100mg   2123606      per 60 

Please find data for your request provided within the tables below. 

Table 1: Number of packs dispensed in the community between 1 January to 31 December 2021

Brand Formulation Calendar year Packs dispensed
Glivec Tab 100 mg 2021 1,436
Imatinib-Rex Cap 100 mg 2021 2,057
Imatinib-Rex Cap 400 mg 2021 2,981

Table 2: Number of packs purchased in DHB hospitals between 1 January to 31 December 2021

Brand Formulation Calendar year Packs purchased
Imatinib-Rex Cap 100 mg 2021 18
Imatinib-Rex Cap 400 mg 2021 12

Note: Figures in Table 2 are based on purchase data provided by DHBs. Pharmac makes no representation as to the accuracy of the figures provided. 

We trust that this information answers your queries. We are making our information more freely available, so we now publish selected OIA responses (excluding personal details) on our website. Please get in touch with us if you have any questions about this.